Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Kylo 11

Next Previous
Drug Profile

Kylo 11

Alternative Names: Kylo-11

Latest Information Update: 14 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kylonova (Xiamen) Biopharma
  • Class Antihyperlipidaemics; Cardiovascular therapies; Small interfering RNA
  • Mechanism of Action RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Hyperlipoproteinaemia
  • Phase I Cardiovascular disorders

Most Recent Events

  • 08 Nov 2025 Pharmacodynmics and adverse events data from a phase I trial in Cardiovascular disorders (In volunteers) presented at the American Heart Association Scientific Sessions 2025 (AHA-2025)
  • 29 Oct 2025 Phase-II clinical trials in Hyperlipoproteinaemia in China (SC) (NCT07327840)
  • 18 Apr 2024 Kylonova (Xiamen) Biopharma plans a phase I trial for Cardiovascular disorders (In volunteers) in China (SC) in May 2024 (NCT06363851)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top